Novel Therapies for LDL-C Lowering in the Fight Against Residual ASCVD Risk - A Quick-Fire

This Quick-Fire Challenge, features video snippets and key slides from the 2015 CMHC Annual meeting. The activity examines current lipid guidelines, the unmet need and residual risk of poorly controlled LDL-C, and exciting genetic insights that have expanded treatment targets. This straightforward assessment of questions cover the latest information on novel LDL lowering therapies, including PCSK9 inhibitors. Learners are invited to answer 1 question every few days, delivered through convenient web or mobile devices relating to clinical case problem-solving, knowledge, or competence for learners.

Novel Therapies for LDL-C Lowering in the Fight Against Residual ASCVD Risk

CMHC Quick - Fire CME is online learning radically simplified.

Select

a course to be
delivered to you

Choose Your Challenge.

Courses provided test your knowledge on the most current strategies for the prevention, diagnosis, and management of cardiometabolic risk and related comorbidities.

Learn

through answering
questions

Courses consist entirely of questions and answers.

They are sent to you in small amounts (typically 1 or 2 a day) on a regular schedule via email, the Web or RSS. They can be accessed from a desktop browser or a mobile device such as an iPhone or BlackBerry.

Remember

and master the
material

Questions repeat based on your answers.

The sequence of questions will adapt based on your answers. Get a question wrong and it repeats. Get it right and it is retired from the course. Retire all questions to complete the course.

A fun, convenient way to learn and proven to work.

Q Stream
Faculty:
Christie M. Ballantyne, MD